UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 09,
NanoViricides (AMEX:NNVC)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more NanoViricides Charts.
NanoViricides (AMEX:NNVC)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more NanoViricides Charts.

Nanoviricides, Inc. News

Form 8-K - Current report
Saturday 17 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 20 January 2024 (3 months ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Tuesday 5 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Saturday 14 October 2023 (7 months ago) • Edgar (US Regulatory)
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Friday 29 September 2023 (7 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 2 September 2023 (8 months ago) • Edgar (US Regulatory)
Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs
Friday 7 July 2023 (10 months ago) • InvestorsHub NewsWire
NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City
Thursday 4 May 2023 (12 months ago) • GlobeNewswire Inc.

More Nanoviricides, Inc. News Articles